These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1309 related articles for article (PubMed ID: 26903481)

  • 1. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
    Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
    J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis.
    Brisse E; Imbrechts M; Mitera T; Vandenhaute J; Wouters CH; Snoeck R; Andrei G; Matthys P
    Virol J; 2017 Dec; 14(1):240. PubMed ID: 29258535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis.
    Brisse E; Imbrechts M; Mitera T; Vandenhaute J; Berghmans N; Boon L; Wouters C; Snoeck R; Andrei G; Matthys P
    Clin Exp Immunol; 2018 Apr; 192(1):104-119. PubMed ID: 29178470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Ailal F; Bousfiha A; Deswarte C; Oleaga-Quintas C; Casanova JL; Bustamante J; Liston A
    J Allergy Clin Immunol; 2019 Jun; 143(6):2215-2226.e7. PubMed ID: 30578871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders.
    Brisse E; Wouters CH; Matthys P
    Cytokine Growth Factor Rev; 2015 Jun; 26(3):263-80. PubMed ID: 25466631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management.
    Morimoto A; Nakazawa Y; Ishii E
    Pediatr Int; 2016 Sep; 58(9):817-25. PubMed ID: 27289085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis.
    Huang R; Hayashi Y; Yan X; Bu J; Wang J; Zhang Y; Zhou Y; Tang Y; Wu L; Xu Z; Liu X; Wang Q; Zhou J; Xiao Z; Bridges JP; Marsh RA; Zhang K; Jordan MB; Li Y; Huang G
    Haematologica; 2017 Nov; 102(11):1956-1968. PubMed ID: 28860338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis.
    Crozat K; Hoebe K; Ugolini S; Hong NA; Janssen E; Rutschmann S; Mudd S; Sovath S; Vivier E; Beutler B
    J Exp Med; 2007 Apr; 204(4):853-63. PubMed ID: 17420270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagocytic lymphohistiocytosis (HLH) and related disorders.
    Filipovich AH
    Hematology Am Soc Hematol Educ Program; 2009; ():127-31. PubMed ID: 20008190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophagoctic lymphohistiocytosis--recent concept.
    Bhattacharyya M; Ghosh MK
    J Assoc Physicians India; 2008 Jun; 56():453-7. PubMed ID: 18822626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic murine typhoid fever is a natural model of secondary hemophagocytic lymphohistiocytosis.
    Brown DE; McCoy MW; Pilonieta MC; Nix RN; Detweiler CS
    PLoS One; 2010 Feb; 5(2):e9441. PubMed ID: 20195482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cell Function Tests by Flowcytometry-Based Cytotoxicity and IFN-γ Production for the Diagnosis of Adult Hemophagocytic Lymphohistiocytosis.
    Lee H; Kim HS; Lee JM; Park KH; Choi AR; Yoon JH; Ryu H; Oh EJ
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary hemophagocytic syndromes].
    Buda P; Gietka P; Wieteska-Klimczak A; Ksiazyk J
    Wiad Lek; 2013; 66(2 Pt 2):153-63. PubMed ID: 25775810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current and future directions of pathologic analysis in hemophagocytic syndrome].
    Ishii E; Nagai K
    Nihon Rinsho; 2012 Jun; 70(6):1059-67. PubMed ID: 22690617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis.
    Yang SL; Xu XJ; Tang YM; Song H; Xu WQ; Zhao FY; Shen DY
    Cytokine; 2016 Sep; 85():14-7. PubMed ID: 27269180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic significance of Th1/Th2 cytokine pattern in childhood hemophagocytic lymphohistiocytosis].
    Xu XJ; Tang YM; Zhao N; Song H; Yang SL; Shi SW; Xu WQ; Pan BH; Zhang LY; Mao JQ; Shen HP; Gu ME; Xia J
    Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):685-9. PubMed ID: 22176904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
    J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis.
    Gather R; Aichele P; Goos N; Rohr J; Pircher H; Kögl T; Zeiser R; Hengel H; Schmitt-Gräff A; Weaver C; Ehl S
    Eur J Immunol; 2020 Nov; 50(11):1770-1782. PubMed ID: 32419134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.